Author
Elsmarieke van de Giessen
Recent research
- Health & MedicineOpen access
Clinical trials of amyloid-targeting therapies (ATTs) for Alzheimer's Disease (AD) showed slowing of decline in continuous cognitive and functional outcomes over eighteen months of follow-up. Existing simulation models used to extrapolate these results do not account for the dist...